SOM Biotech attended the BIO International Convention 2020

SOM Biotech attended the BIO International Convention 2020 in its virtual format “BIO Digital” on June 8^th – 12^th.

The virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportunities for future drug discovery and development projects.

Raul Insa, CEO of SOM Biotech: “We have shared with potential partners details on the latest developments of our pipeline, and especially the positive results obtained, among others, from the clinical trials related to SOM3355 for Chorea in Huntington’s disease. The recently developed program for three COVID-19 compounds has also drawn a lot of interest from pharmaceutical companies, as well as the opportunities for partnerships that may arise from taking advantage of SOM Biotech´s proprietary AI- drug discovery technology, allowing to optimize and speed the identification of potential drug candidates for specific indications”.